|Articles|September 8, 2022
Supplements and Featured Publications
- Best Practices and Future Opportunities in Care Delivery for Severe, Uncontrolled Asthma: an AJMC® Profiles in Care
Best Practices and Future Opportunities in Care Delivery for Severe, Uncontrolled Asthma: an AJMC® Profiles in Care
Advertisement
This resource was sponsored by Amgen.
Editors from AJMC® spoke with key opinion leaders from the Cleveland Clinic, National Jewish Health, and the University of Pittsburgh Medical Center Children’s Hospital to discuss multidisciplinary asthma care practices at their respective institutions, ways to track and optimize patient outcomes, and the challenges and unmet needs of managing severe, uncontrolled asthma.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
FDA Clears First Alzheimer Blood Test for Adults as Young as 40
2
MFN Drug Agreements Could Raise Prices Worldwide
3
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
4
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
5

